ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”

June 3, 1994

New Publication Describes End-of-Life Care Projects

August 29, 2003

DCE Advisors Approve New Grant Program On Lung Carcinoma

June 30, 1995

Study Explores Reasons Women Avoid Mammograms

February 25, 2011

Breast Cancer Rates Decline Most for Affluent White Women

February 26, 2010

New Recommendations made For Radiation Protection Standards

August 14, 1987